Interleukin-19 impairment in active Crohn's disease patients

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Cantó, Elisabet ^a   Garcia Planella, Esther ^b   Zamora Atenza, Carlos ^a   Nieto, Juan Camilo ^a   Gordillo, Jordi ^b   Ortiz, Ma Angels ^a   Metón, Isidoro ^c   Serrano, Elena ^a   Vegas, Esteban ^c   García Bosch, Orlando ^d   Juárez, Cándido ^b,e   Vidal, Sílvia ^a,e  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Hospital de Sant Joan Despi Moises Broggi   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 19; INTERLEUKIN 4; MESSENGER RNA; MICRORNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; CTLA4 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; IL19 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; RECOMBINANT PROTEIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IL19 GENE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; T LYMPHOCYTE; UPREGULATION; AGED; BIOSYNTHESIS; BLOOD; CELL CULTURE; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PHYSIOLOGY; SECRETION (PROCESS); TH2 CELL;

ADULT; AGED; CELLS, CULTURED; CROHN DISEASE; CTLA-4 ANTIGEN; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MICRORNAS; MIDDLE AGED; MONOCYTES; RECOMBINANT PROTEINS; TH2 CELLS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899751880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093910     Document Type: Article

References (41)

1. Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, et al. (2000) Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 1: 442-450.
2. Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC (2001) Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 167: 3545-3549. (Pubitemid 32910793)
3. Zdanov A (2010) Structural analysis of cytokines comprising the IL-10 family. Cytokine Growth Factor Rev 21: 325-330.
4. Oral HB, Kotenko SV, Yilmaz M, Mani O, Zumkehr J, et al. (2006) Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol 36: 380-388. (Pubitemid 43257461)
5. Jordan WJ, Eskdale J, Boniotto M, Lennon GP, Peat J, et al. (2005) Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10. Eur J Immunol 35: 1576-1582. (Pubitemid 40691438)
6. Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, et al. (2002) IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNFalpha. J Immunol 169: 4288-4297.
7. Yeh CH, Cheng BC, Hsu CC, Chen HW, Wang JJ, et al. (2011) Induced interleukin-19 contributes to cell-mediated immunosuppression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Ann Thorac Surg 92: 1252-1259.
8. Liao SC, Cheng YC, Wang YC, Wang CW, Yang SM, et al. (2004) IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J Immunol 173: 6712-6718.
9. Hsing CH, Hsu CC, Chen WY, Chang LY, Hwang JC, et al. (2007) Expression of IL-19 correlates with Th2 cytokines in uraemic patients. Nephrol Dial Transplant 22: 2230-2238. (Pubitemid 47244701)
10. Li HH, Lin YC, Chen PJ, Hsiao CH, Lee JY, et al. (2005) Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br J Dermatol 153: 591-595. (Pubitemid 41248218)
11. Sun DP, Yeh CH, So E, Wang LY, Wei TS, et al. (2013) Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression. Cytokine 62: 360-368.
12. Hsing CH, Li HH, Hsu YH, Ho CL, Chuang SS, et al. (2008) The distribution of interleukin-19 in healthy and neoplastic tissue. Cytokine 44: 221-228.
13. Chen YY, Li CF, Yeh CH, Chang MS, Hsing CH (2013) Interleukin-19 in breast cancer. Clin Dev Immunol 2013: 294320.
14. Hsing CH, Chiu CJ, Chang LY, Hsu CC, Chang MS (2008) IL-19 is involved in the pathogenesis of endotoxic shock. Shock 29: 7-15.
15. Pace E, Scafidi V, Di Bona D, Siena L, Chiappara G, et al. (2012) Increased expression of IL-19 in the epithelium of patients with chronic rhinosinusitis and nasal polyps. Allergy 67: 878-886.
16. England RN, Preston KJ, Scalia R, Autieri MV (2013) Interleukin-19 Decreases Leukocyte-Endothelial Cell Interactions by Reduction in Endothelial Cell Adhesion Molecule mRNA Stability. Am J Physiol Cell Physiol.
17. England RN, Autieri MV (2012) Anti-inflammatory effects of interleukin-19 in vascular disease. Int J Inflam 2012: 253583.
18. Gabunia K, Jain S, England RN, Autieri MV (2011) Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility. Am J Physiol Cell Physiol 300: C896-906.
19. Hsu YH, Hsieh PP, Chang MS (2012) Interleukin-19 blockade attenuates collagen-induced arthritis in rats. Rheumatology (Oxford) 51: 434-442.
20. Alanara T, Karstila K, Moilanen T, Silvennoinen O, Isomaki P (2010) Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints. Scand J Rheumatol 39: 118-126.
21. Sakurai N, Kuroiwa T, Ikeuchi H, Hiramatsu N, Maeshima A, et al. (2008) Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. Rheumatology (Oxford) 47: 815-820. (Pubitemid 351796366)
22. Azuma YT, Matsuo Y, Kuwamura M, Yancopoulos GD, Valenzuela DM, et al. (2010) Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflamm Bowel Dis 16: 1017-1028.
23. Canto E, Ricart E, Monfort D, Gonzalez-Juan D, Balanzo J, et al. (2006) TNF alpha production to TLR2 ligands in active IBD patients. Clin Immunol 119: 156-165.
24. Beltran CJ, Candia E, Erranz B, Figueroa C, Gonzalez MJ, et al. (2009) Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis. Eur Cytokine Netw 20: 33-38.
25. Garcia de Tena J, Manzano L, Leal JC, San Antonio E, Sualdea V, et al. (2006) Distinctive pattern of cytokine production and adhesion molecule expression in peripheral blood memory CD4+ T cells from patients with active Crohn's disease. J Clin Immunol 26: 233-242. (Pubitemid 43901652)
26. Strober W, Ludviksson BR, Fuss IJ (1998) The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann Intern Med 128: 848-856. (Pubitemid 28267719)
27. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, et al. (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253-261. (Pubitemid 23320289)
28. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274. (Pubitemid 23320290)
29. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, et al. (2007) Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 178: 7520-7524. (Pubitemid 46898019)
30. Bianchini R, Bistoni O, Alunno A, Petrillo MG, Ronchetti S, et al. (2011) CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity. Eur J Immunol 41: 2269-2278.
31. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-158. (Pubitemid 351149713)
32. Gallagher G (2010) Interleukin-19: multiple roles in immune regulation and disease. Cytokine Growth Factor Rev 21: 345-352.
33. Guarnieri DJ, DiLeone RJ (2008) MicroRNAs: a new class of gene regulators. Ann Med 40: 197-208. (Pubitemid 351482548)
34. Schaefer JS, Montufar-Solis D, Vigneswaran N, Klein JR (2011) Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-102/2 mice precedes expression in the colon. J Immunol 187: 5834-5841.
35. Nimmo ER, Prendergast JG, Aldhous MC, Kennedy NA, Henderson P, et al. (2012) Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway. Inflamm Bowel Dis 18: 889-899.
36. Hofmann SR, Moller J, Rauen T, Paul D, Gahr M, et al. (2012) Dynamic CpG-DNA methylation of Il10 and Il19 in CD4+ T lymphocytes and macrophages: effects on tissue-specific gene expression. Klin Padiatr 224: 53-60.
37. Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, et al. (2002) Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem 277: 47517-47523. (Pubitemid 36159270)
38. Wolk K, Kunz S, Asadullah K, Sabat R (2002) Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol 168: 5397-5402. (Pubitemid 34556115)
39. Gallagher G, Eskdale J, Jordan W, Peat J, Campbell J, et al. (2004) Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses. Int Immunopharmacol 4: 615-626. (Pubitemid 38553883)
40. Wahl C, Muller W, Leithauser F, Adler G, Oswald F, et al. (2009) IL-20 receptor 2 signaling down-regulates antigen-specific T cell responses. J Immunol 182: 802-810.
41. Kunz S, Wolk K, Witte E, Witte K, Doecke WD, et al. (2006) Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol 15: 991-1004. (Pubitemid 44688369)